Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 212

1.

Antibody responses to prime-boost vaccination with an HIV-1 gp145 envelope protein and chimpanzee adenovirus vectors expressing HIV-1 gp140.

Emmer KL, Wieczorek L, Tuyishime S, Molnar S, Polonis VR, Ertl HC.

AIDS. 2016 Oct 23;30(16):2405-2414.

PMID:
27525550
2.

A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products.

Haut LH, Gill AL, Kurupati RK, Bian A, Li Y, Giles-Davis W, Xiang Z, Zhou XY, Ertl HC.

Hum Gene Ther Methods. 2016 Sep 7. [Epub ahead of print]

PMID:
27604324
3.

Viral vectors as vaccine carriers.

Ertl HC.

Curr Opin Virol. 2016 Jun 18;21:1-8. doi: 10.1016/j.coviro.2016.06.001. [Epub ahead of print] Review.

PMID:
27327517
4.

Aging: T cell metabolism within tumors.

Zhang Y, Ertl HC.

Aging (Albany NY). 2016 Jun;8(6):1163-4. doi: 10.18632/aging.100979. No abstract available.

5.

Vaccine Design: Replication-Defective Adenovirus Vectors.

Zhou X, Xiang Z, Ertl HC.

Methods Mol Biol. 2016;1404:329-49. doi: 10.1007/978-1-4939-3389-1_23.

PMID:
27076309
6.

Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid.

Vercauteren K, Hoffman BE, Zolotukhin I, Keeler GD, Xiao JW, Basner-Tschakarjan E, High KA, Ertl HC, Rice CM, Srivastava A, de Jong YP, Herzog RW.

Mol Ther. 2016 Jun;24(6):1042-9. doi: 10.1038/mt.2016.61.

PMID:
27019999
7.

Age-related changes in the transcriptome of antibody-secreting cells.

Kannan S, Dawany N, Kurupati R, Showe LC, Ertl HC.

Oncotarget. 2016 Mar 22;7(12):13340-53. doi: 10.18632/oncotarget.7958.

8.

Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumors.

Zhang Y, Ertl HC.

Oncotarget. 2016 Apr 26;7(17):23282-99. doi: 10.18632/oncotarget.7818.

9.

Starved and Asphyxiated: How Can CD8(+) T Cells within a Tumor Microenvironment Prevent Tumor Progression.

Zhang Y, Ertl HC.

Front Immunol. 2016 Feb 10;7:32. doi: 10.3389/fimmu.2016.00032. Review.

10.

A shortened interval between vaccinations with the trivalent inactivated influenza vaccine increases responsiveness in the aged.

Kannan S, Kossenkov A, Kurupati RK, Xiang JZ, Doyle SA, Schmader KE, Schowe L, Ertl HC.

Aging (Albany NY). 2015 Dec;7(12):1077-85.

11.

BTLA expression declines on B cells of the aged and is associated with low responsiveness to the trivalent influenza vaccine.

Kannan S, Kurupati RK, Doyle SA, Freeman GJ, Schmader KE, Ertl HC.

Oncotarget. 2015 Aug 14;6(23):19445-55.

12.

Gene therapy and gene transfer approaches to prevent or treat chronic virus infections.

Berkout B, Ertl HC, Weinberg MS.

Adv Exp Med Biol. 2015;848:v-vii. No abstract available.

PMID:
26034787
13.

Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation.

Song Y, Wang X, Zhang H, Tang X, Li M, Yao J, Jin X, Ertl HC, Zhou D.

J Virol. 2015 Aug;89(15):7841-51. doi: 10.1128/JVI.00976-15.

14.

Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection.

Jeyanathan M, Thanthrige-Don N, Afkhami S, Lai R, Damjanovic D, Zganiacz A, Feng X, Yao XD, Rosenthal KL, Medina MF, Gauldie J, Ertl HC, Xing Z.

Mucosal Immunol. 2015 Nov;8(6):1373-87. doi: 10.1038/mi.2015.29.

PMID:
25872483
15.

Adenovirus-mediated artificial MicroRNAs targeting matrix or nucleoprotein genes protect mice against lethal influenza virus challenge.

Zhang H, Tang X, Zhu C, Song Y, Yin J, Xu J, Ertl HC, Zhou D.

Gene Ther. 2015 Aug;22(8):653-62. doi: 10.1038/gt.2015.31.

PMID:
25835311
16.

Unique Roles of TLR9- and MyD88-Dependent and -Independent Pathways in Adaptive Immune Responses to AAV-Mediated Gene Transfer.

Rogers GL, Suzuki M, Zolotukhin I, Markusic DM, Morel LM, Lee B, Ertl HC, Herzog RW.

J Innate Immun. 2015;7(3):302-14. doi: 10.1159/000369273.

17.

Activated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques.

Carnathan DG, Wetzel KS, Yu J, Lee ST, Johnson BA, Paiardini M, Yan J, Morrow MP, Sardesai NY, Weiner DB, Ertl HC, Silvestri G.

Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):518-23. doi: 10.1073/pnas.1407466112.

18.

Survivin-targeting Artificial MicroRNAs Mediated by Adenovirus Suppress Tumor Activity in Cancer Cells and Xenograft Models.

Chi Y, Wang X, Yang Y, Zhang C, Ertl HC, Zhou D.

Mol Ther Nucleic Acids. 2014 Nov 4;3:e208. doi: 10.1038/mtna.2014.59.

19.

The effect of adenovirus-specific antibodies on adenoviral vector-induced, transgene product-specific T cell responses.

Small JC, Haut LH, Bian A, Ertl HC.

J Leukoc Biol. 2014 Nov;96(5):821-31. doi: 10.1189/jlb.1A0813-451RR.

20.
Items per page

Supplemental Content

Support Center